Diaceutics Management
Management criteria checks 2/4
Diaceutics' CEO is Ryan Keeling, appointed in Jan 2024, has a tenure of less than a year. total yearly compensation is £282.49K, comprised of 95.2% salary and 4.8% bonuses, including company stock and options. directly owns 3.54% of the company’s shares, worth £3.47M. The average tenure of the management team and the board of directors is 0.8 years and 0.1 years respectively.
Key information
Ryan Keeling
Chief executive officer
UK£282.5k
Total compensation
| CEO salary percentage | 95.2% |
| CEO tenure | less than a year |
| CEO ownership | 3.5% |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Diaceutics PLC (LON:DXRX) Stock Rockets 29% But Many Are Still Ignoring The Company
May 30
Diaceutics PLC's (LON:DXRX) Subdued P/S Might Signal An Opportunity
Jan 31Industry Analysts Just Made A Notable Upgrade To Their Diaceutics PLC (LON:DXRX) Revenue Forecasts
Jan 28Estimating The Intrinsic Value Of Diaceutics PLC (LON:DXRX)
Jul 24Would Shareholders Who Purchased Diaceutics' (LON:DXRX) Stock Year Be Happy With The Share price Today?
Feb 04
Here's Why We Don't Think Diaceutics's (LON:DXRX) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 31Do Insiders Own Lots Of Shares In Diaceutics PLC (LON:DXRX)?
Nov 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -UK£3m |
| Mar 31 2024 | n/a | n/a | -UK£2m |
| Dec 31 2023 | UK£282k | UK£269k | -UK£2m |
| Sep 30 2023 | n/a | n/a | -UK£870k |
| Jun 30 2023 | n/a | n/a | UK£6k |
| Mar 31 2023 | n/a | n/a | UK£365k |
| Dec 31 2022 | UK£334k | UK£252k | UK£724k |
| Sep 30 2022 | n/a | n/a | UK£427k |
| Jun 30 2022 | n/a | n/a | UK£129k |
| Mar 31 2022 | n/a | n/a | UK£345k |
| Dec 31 2021 | UK£231k | UK£220k | UK£561k |
| Sep 30 2021 | n/a | n/a | -UK£294k |
| Jun 30 2021 | n/a | n/a | -UK£1m |
| Mar 31 2021 | n/a | n/a | -UK£443k |
| Dec 31 2020 | UK£225k | UK£215k | UK£263k |
| Sep 30 2020 | n/a | n/a | UK£2m |
| Jun 30 2020 | n/a | n/a | UK£3m |
| Mar 31 2020 | n/a | n/a | UK£2m |
| Dec 31 2019 | UK£236k | UK£175k | UK£398k |
| Sep 30 2019 | n/a | n/a | UK£124k |
| Jun 30 2019 | n/a | n/a | -UK£151k |
| Mar 31 2019 | n/a | n/a | UK£241k |
| Dec 31 2018 | UK£78k | n/a | UK£632k |
Compensation vs Market: Ryan's total compensation ($USD354.36K) is about average for companies of similar size in the UK market ($USD354.57K).
Compensation vs Earnings: Ryan's compensation has been consistent with company performance over the past year.
CEO
Ryan Keeling (42 yo)
less than a year
Tenure
UK£282,494
Compensation
Mr. Ryan Keeling serves as Executive Director of Diaceutics PLC, he joined the company in 2006 and serves as Chief Executive Officer since January 1, 2024 and is responsible for the innovation strategy for...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | less than a year | UK£310.99k | 18.65% £ 18.3m | |
| CEO & Director | less than a year | UK£282.49k | 3.54% £ 3.5m | |
| CFO & Director | 2.7yrs | UK£193.05k | 0.050% £ 49.0k | |
| Vice President of Scientific & Medical Services | less than a year | no data | no data | |
| General Counsel | 2.8yrs | no data | no data | |
| Vice President of Marketing | less than a year | no data | no data | |
| Interim VP of Sales | less than a year | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| Chief Data Officer? & Executive Director | less than a year | no data | 0.83% £ 817.4k | |
| Chief Precision Medicine Officer | 5.8yrs | no data | 0.30% £ 289.7k | |
| Chief Commercial Officer | 1.8yrs | no data | no data | |
| VP & Chief of Staff | less than a year | no data | no data |
0.8yrs
Average Tenure
42yo
Average Age
Experienced Management: DXRX's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | less than a year | UK£310.99k | 18.65% £ 18.3m | |
| CEO & Director | no data | UK£282.49k | 3.54% £ 3.5m | |
| CFO & Director | 2.7yrs | UK£193.05k | 0.050% £ 49.0k | |
| Chief Data Officer? & Executive Director | less than a year | no data | 0.83% £ 817.4k | |
| Senior Independent Director | 1.1yrs | UK£15.00k | 0.087% £ 85.3k | |
| Non-Executive Director | less than a year | no data | no data |
0.08yrs
Average Tenure
47.5yo
Average Age
Experienced Board: DXRX's board of directors are not considered experienced ( 0.1 years average tenure), which suggests a new board.